Hearing loss associated with muromonab-CD3 therapy.
Michals
M
M
Roberts
J P
JP
Canafax
D
D
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection; D034381:Hearing Loss / Q000209:etiology*; D006801:Humans
D000911:Antibodies, Monoclonal